Funding for this research was provided by:
Aegerion Pharmaceuticals Ltd (Multiple grants to multiple study sites)
Article History
Received: 23 November 2017
Accepted: 13 June 2018
First Online: 20 June 2018
Ethics approval and consent to participate
: The study was approved by the competent regulatory authorities and the ethics committee or independent review board at each site.
: All authors consent to the publication of this paper in accordance with the guidance set out by the ICMJE.
: MA and HP are paid employees contracted by Aegerion Pharmaceuticals. DB and MC receive honoraria for consultancy and speaking engagements from Aegerion and other companies that produce therapeutics in the field of HoFH.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.